⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTGN News
Vistagen Therapeutics, Inc. Common Stock
VTGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Vistagen Therapeutics, Inc. to Contact the Firm Today!
accessnewswire.com
VTGN
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in Vistagen Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - VTGN
accessnewswire.com
VTGN
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
accessnewswire.com
VTGN
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Vistagen Therapeutics, Inc. (NASDAQ: VTGN)
globenewswire.com
VTGN
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
VTGN
VTGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Vistagen Therapeutics, Inc. to Contact the Firm Today!
accessnewswire.com
VTGN
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) DEADLINE ALERT Bernstein Liebhard LLP Reminds Vistagen Therapeutics, Inc. Investors of Upcoming Deadline
accessnewswire.com
VTGN
Pomerantz LLP Calls Attention to Class Action Against Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Vistagen Therapeutics Ready to Announce with Confidence?
newsfilecorp.com
VTGN
Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
VTGN